Abstract:Background: The low expression of miR93/ 25 (members of miR-106b similar to 25 cluster) promoted the invasion and metastasis of colon cancer cells, which predicted poor survival. However, the role of miR-106b-5p, the member of miR-106b similar to 25 cluster, in colorectal cancer (CRC) remains unclear. Methods: Bioinformatics methods were used to predict the potential pairs of lncRNA-miRNA-mRNA. In situ hybridization and qPCR were used to evaluate the expression of MALAT1 and miR-106b-5p in the paraffinembedded normal and CRC tissues. Kaplan-Meier analysis with the log-rank test was used for survival analyses. Immunohistochemistry stainingwas applied to investigate the expression of SLAIN2. Fluorescence recovery after photobleaching assay was applied to observe the microtubule (MT) mobility. In vitro and in vivo invasion and metastasis assays were used to explore the function of MALAT1/ miR-106b-5p/ SLAIN2 in the progression of CRC. Findings: miR-106b-5p was identified as a suppressor in CRC. Functionally, ectopic or silencing the expression of miR-106b-5p inhibited or promoted the invasion and metastasis of CRC cells in vitro and in vivo. The long noncodingRNAMALAT1 regulated themiR-106b-5p expression and further mediated themobility of SLAIN2-related MTs by functioning as a competing endogenous RNA in vitro and in vivo, which resulted in the progression of CRC. Clinically, low miR-106b-5p expression predicted poor survival of CRC patients, especially in combination with high MALAT1/ SLAIN2 expression. Interpretation: miR-106b-5p served as a suppressor in combination with MALAT1/ miR-106b-5p/ SLAIN2, which might be a group of potential prognostic biomarkers in the prognosis of CRC. Fund: This work was supported by National Program Project for Precision Medicine in National Research and Development Plan of China (2016YFC0905300), National Natural Science Foundation of China (81572930), National Key Research and Development Program of the Ministry of Science and Technology of China (2016YFC0905303, 2016YFC1303200), Beijing Science and Technology Program (D17110002617004), Non-profit Central Research Institute Fund of Chinese Academy ofMedical Sciences (2018PT32012), CAMS Innovation Fund for Medical Sciences (CIFMS) (2016-I2M-1-001), Incentive Fund for Academic Leaders of Oncology Hospital, Chinese Academy of Medical Sciences (RC2016003), and Beijing Hope Run Special Fund from Cancer Foundation of China (LC2017A19). The project of Shanghai Jiaotong Univversity (YG2017QN30). (c) 2018 Published by Elsevier B. V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

Long Noncoding RNA MALAT1 Mediates Stem Cell-Like Properties in Human Colorectal Cancer Cells by Regulating Mir-20B-5p/oct4 Axis

Inhibition of MALAT1 Reduces Tumor Growth and Metastasis and Promotes Drug Sensitivity in Colorectal Cancer

Long Noncoding Rna Malat-1 Enhances Stem Cell-Like Phenotypes In Pancreatic Cancer Cells

CD95 Promotes Stemness of Colorectal Cancer Cells by Lncrna MALAT1

MALAt1 Sponges Mir-106B-5p to Promote the Invasion and Metastasis of Colorectal Cancer Via SLAIN2 Enhanced Microtubules Mobility

High Expression of Lncrna MALAT1 Suggests a Biomarker of Poor Prognosis in Colorectal Cancer.

Long non-coding RNA CCAT1 promotes colorectal cancer progression by regulating miR-181a-5p expression

Upregulation of Long Noncoding RNA MALAT1 in Colorectal Cancer Promotes Radioresistance and Aggressive Malignance

Upregulation of long noncoding RNA MALAT1 in colorectal cancer promotes radioresistance and malignance

MALAT1 promotes the colorectal cancer malignancy by increasing DCP1A expression and miR203 downregulation

MicroRNA expression profile of colon cancer stem-like cells in HT29 adenocarcinoma cell line.

Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1 promotes triple-negative breast cancer development

MALAT1–miR663a Negative Feedback Loop in Colon Cancer Cell Functions Through Direct Mirna–lncrna Binding

RETRACTED: Aberrant expression of lncRNA MALAT1 modulates radioresistance in colorectal cancer in vitro via miR-101-3p sponging

Long noncoding RNA MALAT1 sponging miR-26a-5p to modulate Smad1 contributes to colorectal cancer progression by regulating autophagy

Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex

LncRNA MALAT1 Functions As a Competing Endogenous RNA to Regulate ZEB2 Expression by Sponging Mir-200S in Clear Cell Kidney Carcinoma

CCMAlnc Promotes the Malignance of Colorectal Cancer by Modulating the Interaction Between miR-5001-5p and Its Target mRNA

[Role of Long Noncoding RNA MALAT1 Promotes the Occurrence and Progression of Cutaneous Squamous Cell Carcinoma].

LncRNA MALAT1 accelerates non‐small cell lung cancer progression via regulating miR‐185‐5p/MDM4 axis

Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145